PharmaReports: Metabolic & Hormonal Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports featured here primarily focus on diabetes and obesity. Cachexia is also a focus of this channel as is metabolic dysfunction relating to pharmacological treatment (for example following treatment for HIV infection). Reports relating to hormonal disorders or diseases due to hormonal change (eg osteoporosis) can be featured here.
Showing results 101 - 150 of 169
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- HRT for Menopausal Symptoms: Commercial Opportunities and Pipeline Insight
- Outsourcing in Drug Discovery
- World Wound Care Markets 2008 - Burns, Skin Ulcers, Surgical and Trauma Wounds
- Pipeline Insight: Non-insulin antidiabetics - Incretin mimetics, GLP-1 agonists and DPP-IV inhibitors
- Lipitor Market analysis and forecasts
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Non-hormonal Treatments for Menopausal Symptoms
- World Wound Care Markets 2008
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Osteoporosis & Bone Metabolism Disorders Market 2008-2023
- Pipeline Insight: Insulin antidiabetics
- Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth
- Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking
- Glucose Testing Markets
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
- GPCR Screening & Profiling Trends 2008
- Women's Reproductive Disorders Therapeutics 2008-2018
- Critical Limb Ischemia: Western Europe Epidemiology
- Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
- Protein Therapeutics Markets - Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments
- Innovations in The Management of Diabetes: Next generation treatments and market dynamics
- Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
- Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies
- The Promotional Landscape in US and Europe: Benchmarking promotional ROI and optimizing detailing and journal spend
- Two pharmaceutical reports for the price of one - End of year offer
- Protein Therapeutics Markets: Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines
- Womens Health: Worldwide Prescription Drug Markets
- Pharmaceutical Company Outlook to 2013
- Womens Health 2009: Worldwide Prescription Drug Markets
- Commercial Insight: Cardiovascular and metabolic market overview - Diabetes to the fore as generics hit primary care markets
- Cancer Cachexia - Higher profile needed to unlock market potential of neglected syndrome
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2009
- Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
- Osteoporosis - A market analysis: Generic alendronate further establishes oral bisphosphonates as gold standard
- The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- World Diabetes Market Analysis, 2009-2023
- Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024
- Statins: The World Market, 2009-2024
- Stem Cells - World Analysis 2009-2024
- Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- The Eastern European Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
- Accelerating Lead Generation: Emerging technologies and strategies
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development